Global and United States Drug of Abuse (DOA) Testing Market Report & Forecast 2023-2028

Report ID: 1738470 | Published Date: Jan 2025 | No. of Page: 90 | Base Year: 2024 | Rating: 3.7 | Webstory: Check our Web story
1 Study Coverage
    1.1 Drug of Abuse (DOA) Testing Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Drug of Abuse (DOA) Testing Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Drug of Abuse (DOA) Testing Market Size for the Year 2017-2028
        1.2.2 Global Drug of Abuse (DOA) Testing Market Size for the Year 2017-2028
    1.3 Drug of Abuse (DOA) Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Drug of Abuse (DOA) Testing in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Drug of Abuse (DOA) Testing Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Drug of Abuse (DOA) Testing Market Dynamics
        1.4.1 Drug of Abuse (DOA) Testing Industry Trends
        1.4.2 Drug of Abuse (DOA) Testing Market Drivers
        1.4.3 Drug of Abuse (DOA) Testing Market Challenges
        1.4.4 Drug of Abuse (DOA) Testing Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Drug of Abuse (DOA) Testing by Type
    2.1 Drug of Abuse (DOA) Testing Market Segment by Type
        2.1.1 Urine
        2.1.2 Saliva
        2.1.3 Hair
        2.1.4 Others
    2.2 Global Drug of Abuse (DOA) Testing Market Size by Type (2017, 2022 & 2028)
    2.3 Global Drug of Abuse (DOA) Testing Market Size by Type (2017-2028)
    2.4 United States Drug of Abuse (DOA) Testing Market Size by Type (2017, 2022 & 2028)
    2.5 United States Drug of Abuse (DOA) Testing Market Size by Type (2017-2028)
3 Drug of Abuse (DOA) Testing by Application
    3.1 Drug of Abuse (DOA) Testing Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Laboratories
        3.1.3 Workplace
        3.1.4 At-Home
        3.1.5 Others
    3.2 Global Drug of Abuse (DOA) Testing Market Size by Application (2017, 2022 & 2028)
    3.3 Global Drug of Abuse (DOA) Testing Market Size by Application (2017-2028)
    3.4 United States Drug of Abuse (DOA) Testing Market Size by Application (2017, 2022 & 2028)
    3.5 United States Drug of Abuse (DOA) Testing Market Size by Application (2017-2028)
4 Global Drug of Abuse (DOA) Testing Competitor Landscape by Company
    4.1 Global Drug of Abuse (DOA) Testing Market Size by Company
        4.1.1 Top Global Drug of Abuse (DOA) Testing Companies Ranked by Revenue (2021)
        4.1.2 Global Drug of Abuse (DOA) Testing Revenue by Player (2017-2022)
    4.2 Global Drug of Abuse (DOA) Testing Concentration Ratio (CR)
        4.2.1 Drug of Abuse (DOA) Testing Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Drug of Abuse (DOA) Testing in 2021
        4.2.3 Global Drug of Abuse (DOA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Drug of Abuse (DOA) Testing Headquarters, Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Drug of Abuse (DOA) Testing Headquarters and Area Served
        4.3.2 Global Drug of Abuse (DOA) Testing Companies Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Drug of Abuse (DOA) Testing Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Drug of Abuse (DOA) Testing Market Size by Company
        4.5.1 Top Drug of Abuse (DOA) Testing Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Drug of Abuse (DOA) Testing Revenue by Players (2020, 2021 & 2022)
5 Global Drug of Abuse (DOA) Testing Market Size by Region
    5.1 Global Drug of Abuse (DOA) Testing Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Drug of Abuse (DOA) Testing Market Size by Region (2017-2028)
        5.2.1 Global Drug of Abuse (DOA) Testing Market Size by Region: 2017-2022
        5.2.2 Global Drug of Abuse (DOA) Testing Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Drug of Abuse (DOA) Testing Market Size YoY Growth 2017-2028
        6.1.2 North America Drug of Abuse (DOA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Drug of Abuse (DOA) Testing Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Drug of Abuse (DOA) Testing Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Drug of Abuse (DOA) Testing Market Size YoY Growth 2017-2028
        6.3.2 Europe Drug of Abuse (DOA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Drug of Abuse (DOA) Testing Market Size YoY Growth 2017-2028
        6.4.2 Latin America Drug of Abuse (DOA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Drug of Abuse (DOA) Testing Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Drug of Abuse (DOA) Testing Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Siemens
        7.1.1 Siemens Company Details
        7.1.2 Siemens Business Overview
        7.1.3 Siemens Drug of Abuse (DOA) Testing Introduction
        7.1.4 Siemens Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        7.1.5 Siemens Recent Development
    7.2 Merck
        7.2.1 Merck Company Details
        7.2.2 Merck Business Overview
        7.2.3 Merck Drug of Abuse (DOA) Testing Introduction
        7.2.4 Merck Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        7.2.5 Merck Recent Development
    7.3 Roche
        7.3.1 Roche Company Details
        7.3.2 Roche Business Overview
        7.3.3 Roche Drug of Abuse (DOA) Testing Introduction
        7.3.4 Roche Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        7.3.5 Roche Recent Development
    7.4 Thermo Fisher Scientific
        7.4.1 Thermo Fisher Scientific Company Details
        7.4.2 Thermo Fisher Scientific Business Overview
        7.4.3 Thermo Fisher Scientific Drug of Abuse (DOA) Testing Introduction
        7.4.4 Thermo Fisher Scientific Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        7.4.5 Thermo Fisher Scientific Recent Development
    7.5 Bio-Rad
        7.5.1 Bio-Rad Company Details
        7.5.2 Bio-Rad Business Overview
        7.5.3 Bio-Rad Drug of Abuse (DOA) Testing Introduction
        7.5.4 Bio-Rad Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        7.5.5 Bio-Rad Recent Development
    7.6 Abbott
        7.6.1 Abbott Company Details
        7.6.2 Abbott Business Overview
        7.6.3 Abbott Drug of Abuse (DOA) Testing Introduction
        7.6.4 Abbott Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        7.6.5 Abbott Recent Development
    7.7 Quest Diagnostics
        7.7.1 Quest Diagnostics Company Details
        7.7.2 Quest Diagnostics Business Overview
        7.7.3 Quest Diagnostics Drug of Abuse (DOA) Testing Introduction
        7.7.4 Quest Diagnostics Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        7.7.5 Quest Diagnostics Recent Development
    7.8 Psychemedics
        7.8.1 Psychemedics Company Details
        7.8.2 Psychemedics Business Overview
        7.8.3 Psychemedics Drug of Abuse (DOA) Testing Introduction
        7.8.4 Psychemedics Revenue in Drug of Abuse (DOA) Testing Business (2017-2022)
        7.8.5 Psychemedics Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer
List of Tables
    Table 1. Drug of Abuse (DOA) Testing Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Drug of Abuse (DOA) Testing Market Trends
    Table 3. Drug of Abuse (DOA) Testing Market Drivers
    Table 4. Drug of Abuse (DOA) Testing Market Challenges
    Table 5. Drug of Abuse (DOA) Testing Market Restraints
    Table 6. Global Drug of Abuse (DOA) Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Drug of Abuse (DOA) Testing Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Drug of Abuse (DOA) Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Drug of Abuse (DOA) Testing Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Drug of Abuse (DOA) Testing Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Drug of Abuse (DOA) Testing Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Drug of Abuse (DOA) Testing Revenue Share by Player, 2017-2022
    Table 13. Global Drug of Abuse (DOA) Testing Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Drug of Abuse (DOA) Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug of Abuse (DOA) Testing as of 2021)
    Table 15. Top Players of Drug of Abuse (DOA) Testing in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Drug of Abuse (DOA) Testing Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Drug of Abuse (DOA) Testing Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Drug of Abuse (DOA) Testing Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Drug of Abuse (DOA) Testing Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Drug of Abuse (DOA) Testing Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Drug of Abuse (DOA) Testing Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Drug of Abuse (DOA) Testing Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Drug of Abuse (DOA) Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Drug of Abuse (DOA) Testing Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Drug of Abuse (DOA) Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Drug of Abuse (DOA) Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Drug of Abuse (DOA) Testing Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Siemens Company Details
    Table 31. Siemens Business Overview
    Table 32. Siemens Drug of Abuse (DOA) Testing Product
    Table 33. Siemens Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
    Table 34. Siemens Recent Development
    Table 35. Merck Company Details
    Table 36. Merck Business Overview
    Table 37. Merck Drug of Abuse (DOA) Testing Product
    Table 38. Merck Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
    Table 39. Merck Recent Development
    Table 40. Roche Company Details
    Table 41. Roche Business Overview
    Table 42. Roche Drug of Abuse (DOA) Testing Product
    Table 43. Roche Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
    Table 44. Roche Recent Development
    Table 45. Thermo Fisher Scientific Company Details
    Table 46. Thermo Fisher Scientific Business Overview
    Table 47. Thermo Fisher Scientific Drug of Abuse (DOA) Testing Product
    Table 48. Thermo Fisher Scientific Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
    Table 49. Thermo Fisher Scientific Recent Development
    Table 50. Bio-Rad Company Details
    Table 51. Bio-Rad Business Overview
    Table 52. Bio-Rad Drug of Abuse (DOA) Testing Product
    Table 53. Bio-Rad Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
    Table 54. Bio-Rad Recent Development
    Table 55. Abbott Company Details
    Table 56. Abbott Business Overview
    Table 57. Abbott Drug of Abuse (DOA) Testing Product
    Table 58. Abbott Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
    Table 59. Abbott Recent Development
    Table 60. Quest Diagnostics Company Details
    Table 61. Quest Diagnostics Business Overview
    Table 62. Quest Diagnostics Drug of Abuse (DOA) Testing Product
    Table 63. Quest Diagnostics Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
    Table 64. Quest Diagnostics Recent Development
    Table 65. Psychemedics Company Details
    Table 66. Psychemedics Business Overview
    Table 67. Psychemedics Drug of Abuse (DOA) Testing Product
    Table 68. Psychemedics Revenue in Drug of Abuse (DOA) Testing Business (2017-2022) & (US$ Million)
    Table 69. Psychemedics Recent Development
    Table 70. Research Programs/Design for This Report
    Table 71. Key Data Information from Secondary Sources
    Table 72. Key Data Information from Primary Sources
List of Figures
    Figure 1. Drug of Abuse (DOA) Testing Product Picture
    Figure 2. Global Drug of Abuse (DOA) Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Drug of Abuse (DOA) Testing Market Size 2017-2028 (US$ Million)
    Figure 4. United States Drug of Abuse (DOA) Testing Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Drug of Abuse (DOA) Testing Market Size 2017-2028 (US$ Million)
    Figure 6. United States Drug of Abuse (DOA) Testing Market Share in Global 2017-2028
    Figure 7. Drug of Abuse (DOA) Testing Report Years Considered
    Figure 8. Product Picture of Urine
    Figure 9. Product Picture of Saliva
    Figure 10. Product Picture of Hair
    Figure 11. Product Picture of Others
    Figure 12. Global Drug of Abuse (DOA) Testing Market Share by Type in 2022 & 2028
    Figure 13. Global Drug of Abuse (DOA) Testing Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
    Figure 15. United States Drug of Abuse (DOA) Testing Market Share by Type in 2022 & 2028
    Figure 16. United States Drug of Abuse (DOA) Testing Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Drug of Abuse (DOA) Testing Market Share by Type (2017-2028)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Laboratories
    Figure 20. Product Picture of Workplace
    Figure 21. Product Picture of At-Home
    Figure 22. Product Picture of Others
    Figure 23. Global Drug of Abuse (DOA) Testing Market Share by Application in 2022 & 2028
    Figure 24. Global Drug of Abuse (DOA) Testing Market Size by Application (2017-2028) & (US$ Million)
    Figure 25. Global Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
    Figure 26. United States Drug of Abuse (DOA) Testing Market Share by Application in 2022 & 2028
    Figure 27. United States Drug of Abuse (DOA) Testing Market Size by Application (2017-2028) & (US$ Million)
    Figure 28. United States Drug of Abuse (DOA) Testing Market Share by Application (2017-2028)
    Figure 29. North America Drug of Abuse (DOA) Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 30. U.S. Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Canada Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Europe Drug of Abuse (DOA) Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 33. Germany Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. France Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. U.K. Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Italy Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Russia Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Asia-Pacific Drug of Abuse (DOA) Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 39. China Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Japan Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. South Korea Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. India Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Australia Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Taiwan Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Indonesia Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Thailand Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Malaysia Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Philippines Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Latin America Drug of Abuse (DOA) Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Mexico Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Brazil Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Argentina Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Middle East & Africa Drug of Abuse (DOA) Testing Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 54. Turkey Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Saudi Arabia Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. U.A.E Drug of Abuse (DOA) Testing Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 57. Siemens Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022)
    Figure 58. Merck Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022)
    Figure 59. Roche Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022)
    Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022)
    Figure 61. Bio-Rad Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022)
    Figure 62. Abbott Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022)
    Figure 63. Quest Diagnostics Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022)
    Figure 64. Psychemedics Revenue Growth Rate in Drug of Abuse (DOA) Testing Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Siemens
Merck
Roche
Thermo Fisher Scientific
Bio-Rad
Abbott
Quest Diagnostics
Psychemedics
Frequently Asked Questions
Drug of Abuse (DOA) Testing report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Drug of Abuse (DOA) Testing report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Drug of Abuse (DOA) Testing report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Solar Encapsulant

Solar Encapsulant market is segmented by region (country), players, by Type and by Application. P ... Read More